NEUROSENSE THERAPEUTICS LTD NRSN
ASignal's systematic analysis rates NRSN as Bearish.
Reflects the latest available analysis · analyzed Nov 15, 2026
The case on NRSN
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- RSI near oversold level (35.25) suggests potential downside reversal
- MACD histogram is positive and expanding, indicating weakening bearish momentum
- Price is above the Bollinger Lower Band (1.13), suggesting no extreme capitulation
- Negative MACD (-0.677) below signal line indicates ongoing downtrend
- Price trading well below SMA20 (1.998) and SMA50 (4.138), signaling strong technical weakness
- Extremely weak fundamentals: negative book value, negative margins, and negative ROE (-2174.98%)
- Negative free cash flow (-$3.87M) and operating cash flow (-$7.67M) indicate deteriorating financial health
- Current ratio (0.31x) and quick ratio (0.08x) signal severe liquidity risk
See the full verdict on NRSN
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes NRSN
Most investors never get a second opinion, let alone several. ASignal runs NRSN past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.